Previous studies indicated that GLUD1 is involved in the development of glioblastoma, lung cancer, breast cancer, and kidney cancer (Jin et al., 2015; Yang et al., 2020; Shao et al., 2022) and affects cellular growth, invasion, and glutamine metabolism. Here, GLUD1 is linked to breast carcinoma.